SARS-COV-2 (COVID-19) IGM/IGG AB RAPID TEST
The SARS-CoV-2 IgM/IgG Ab Rapid Test is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It it to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.
The test provides preliminary test results. Negative results don't preclude SARS-CoV-2 infection and they cannot be used as the sole basis for treatment or other management decision.
COVID-19, it is a novel coronavirus with new strain thathas not been previously identified in humans, belongs to Coronaviruses (CoV) suchas Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome(SARS-CoV).
40T/box, 48 boxes/ctn
Fast Reaction: 15 minutes
IgM Sensitivity: 82%
IgM Specificity: 97%
IgG Sensitivity: 93%
IgG Specificity: 97.5%
Positive Coincident Rate: ≥82%
Negative Coincident Rate: ≥96%
Note: Results compared to molescular tersting.